CME Group Inc. $CME Shares Sold by AustralianSuper Pty Ltd

AustralianSuper Pty Ltd decreased its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 19.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 338,232 shares of the financial services provider’s stock after selling 83,477 shares during the period. AustralianSuper Pty Ltd owned approximately 0.09% of CME Group worth $93,224,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the business. Great Lakes Advisors LLC raised its holdings in CME Group by 2.3% in the 1st quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider’s stock valued at $441,000 after acquiring an additional 37 shares during the last quarter. Beaumont Financial Advisors LLC increased its position in CME Group by 2.0% during the second quarter. Beaumont Financial Advisors LLC now owns 1,952 shares of the financial services provider’s stock worth $538,000 after purchasing an additional 38 shares during the last quarter. Whittier Trust Co. of Nevada Inc. increased its position in CME Group by 0.8% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 5,021 shares of the financial services provider’s stock worth $1,384,000 after purchasing an additional 38 shares during the last quarter. Trifecta Capital Advisors LLC increased its position in CME Group by 59.2% during the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after purchasing an additional 42 shares during the last quarter. Finally, OneAscent Financial Services LLC increased its position in CME Group by 4.0% during the first quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider’s stock worth $293,000 after purchasing an additional 43 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Price Performance

Shares of CME opened at $269.54 on Monday. CME Group Inc. has a 1-year low of $213.94 and a 1-year high of $290.79. The stock has a market cap of $97.14 billion, a PE ratio of 26.12, a P/E/G ratio of 6.65 and a beta of 0.41. The firm has a 50-day simple moving average of $266.47 and a two-hundred day simple moving average of $271.90. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same period last year, the business earned $2.68 earnings per share. The business’s revenue for the quarter was down 3.0% on a year-over-year basis. As a group, analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were issued a $1.25 dividend. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group’s payout ratio is 48.45%.

Analyst Ratings Changes

Several research firms recently issued reports on CME. JPMorgan Chase & Co. raised their price objective on shares of CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a research report on Tuesday, October 14th. The Goldman Sachs Group raised their price objective on shares of CME Group from $262.00 to $263.00 and gave the stock a “sell” rating in a research report on Thursday. Wall Street Zen cut shares of CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 13th. Deutsche Bank Aktiengesellschaft upgraded shares of CME Group from a “hold” rating to a “buy” rating and raised their price objective for the stock from $266.00 to $300.00 in a research report on Thursday. Finally, Piper Sandler raised their price objective on shares of CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 15th. Eight equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $284.53.

View Our Latest Stock Report on CME

Insider Buying and Selling at CME Group

In other CME Group news, Director William R. Shepard acquired 262 shares of the company’s stock in a transaction that occurred on Thursday, September 25th. The stock was purchased at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the completion of the acquisition, the director owned 258,459 shares of the company’s stock, valued at approximately $68,540,742.21. This trade represents a 0.10% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of CME Group stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the transaction, the general counsel owned 7,851 shares of the company’s stock, valued at $2,056,962. This trade represents a 4.76% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 13,043 shares of company stock worth $3,527,956. 0.30% of the stock is currently owned by company insiders.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.